Participants 94 114 4
in diabetic patients
Participants 337 440 3
in diabetic patients after sirolimus-eluting stent (SES) or paclitaxel-eluting stent (PES) implantation
Participants 473 552 4
Diabetic patients with de novo coronary lesions (169 patients with 190 lesions)
